Clinical Trial Update: X-Seal EU Post-Market Clinical Follow-Up Protocol [NA]

View source ↗

Summary

Completed post-market clinical follow-up protocol for X-Seal EU; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Arteriotomy Closure

Drugs mentioned

• X-Seal

Snippet

Sponsor: Essential Medical, Inc. | Conditions: Femoral Arteriotomy Closure | NA | Status: COMPLETED | Results posted: 2018-10-29